Sean Dulloo - University of Leicester, University Hospitals of Leicester

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

257 SynthEtic LEthal Cancer Therapy in Mesothelioma (selectmeso): a Molecularly Stratified Multi-Arm Phase II Platform Trial for Patients with Relapsed Malignant Mesothelioma

Hill Kayleigh,Fennell Dean,Knox Emma, Song Anna,Cave Judith,Corkhill Andrea, Hahne Jens, Lattimore Michele,Jordan Peter-Wells, Edensor Samantha,Nusrat Nada,Dulloo Sean,Poile Charlotte, Ibrahim Tasneem, Dungey Maurice,Griffiths Gareth

Lung Cancer (2025): 108366

引用0浏览0引用

86 Real World Outcomes of Patients Receiving Neoadjuvant Treatment for Non-Small Cell Lung Cancer

Chauhan Hiten, Yeo Daniel,Dulloo Sean,Ahmed Samreen,Chauhan Meera, Adhikaree Jason,Khan Sam

Lung Cancer (2025): 108196

引用0浏览0引用

Targeting DNA Damage Response Deficiency in Thoracic Cancers

Aleksandra Bzura,Jake B. Spicer,Sean Dulloo,Timothy A. Yap,Dean A. Fennell

Drugs (2024)

引用0浏览0WOS引用

Phase 2 Study to Evaluate the Novel Mitochondrial PRX3 Inhibitor, RSO-021, As an Intrapleural Monotherapy and in Combination with IV Paclitaxel in Patients with Malignant Pleural Effusion Due to Mesothelioma or Another Advanced Solid Tumor

G. Naumov,S. Dulloo,D. Fennell,S. Lord,F. Thistlethwaite, N. Maskell,S. Popat,K. Blyth,P. Szlosarek, A. Aujayeb, K. Franks, J. Herrero,B. Cunniff, J. Duncan, P. Graham,A. Bexon,J. Spicer

EUROPEAN JOURNAL OF CANCER (2024): S56-S56

引用0浏览0引用

Bilateral Optic Neuritis Attributed to Pembrolizumab: A Case Report

Lucy G. Faulkner,Oyeyemi Akala,Meera Chauhan,Sean Dulloo

CURRENT PROBLEMS IN CANCER CASE REPORTS (2024)

引用0浏览0引用

First-in-human Phase I Clinical Trial of RSO-021, a First-in Class Covalent Inhibitor of Mitochondrial Peroxiredoxin 3 (PRX3), in Patients with Malignant Pleural Effusion Due to Mesothelioma and Other Advanced Solid Tumors (MITOPE)

Dean Anthony Fennell,Sean Dulloo,Simon Lord,Fiona Thistlethwaite,Kevin G. Blyth,Peter Wojciech Szlosarek, Nick Maskell,Sanjay Popat, Avinash Aujayeb, Burak Y. Aktas, Sohail Rooman Javed, Julio Herrero Colomina,Brian Cunniff,Jarrett Duncan, Philippa Graham,Alice Susannah Bexon,George N. Naumov,James F. Spicer

Journal of Clinical Oncology（2024）

引用0浏览0引用

208 SynthEtic LEthal Cancer Therapy in Mesothelioma (selectmeso): a Molecularly Stratified Multi-Arm Phase II Platform Trial for Patients with Relapsed Malignant Mesothelioma

Kayleigh Hill,Dean Fennell, Anna Song,Robin Wickens,Judith Cave,Andrea Corkhill, Jens Hahne,Michelle Lattimore,Peter Wells-Jordan,Nada Nusrat,Sean Dulloo,Charlotte Poile,Gareth Griffiths

Lung Cancer (2024): 107769-107769

引用0浏览0引用

135 (PB123): MITOPE: Phase 2 Evaluation of RSO-021, a Novel Mitochondrial PRX3 Inhibitor, As a Monotherapy and in Combination with Paclitaxel in Patients with Malignant Pleural Effusion Due to Mesothelioma or Other Advanced Solid Tumors

G. Naumov,S. Dulloo,D. Fennell,S. Lord,F. Thistlethwaite, N. Maskell,S. Popat,K. Blyth,P. Szlosarek, A. Aujayeb, K. Franks, J. Herrero,B. Cunniff, J. Duncan, P. Graham,A. Bexon,J. Spicer

European Journal of Cancer (2024): 114658

引用0浏览0引用

Niraparib and Dostarlimab Efficacy in Patients with Platinum-Sensitive Relapsed Mesothelioma: MIST5, a Phase IIa Clinical Trial

Dean Anthony Fennell,Amy Branson,Amy King,Charlotte Poile,Shaun Barber, Marina Antoniou,Liz Darlison,Paul Taylor,Molly Scotland, Clare Belcher,Amrita Bajaj,Bruno Morgan,Cassandra Brookes,Peter Wells-Jordan,Sean Dulloo

Journal of Clinical Oncologyno. 16_suppl (2024): 8017-8017

引用0浏览0引用

G. Naumov,S. Dulloo,D. Fennell,S. Lord,F. Thistlethwaite, N. Maskell,S. Popat,K. Blyth,P. Szlosarek, A. Aujayeb, K. Franks, J. Herrero,B. Cunniff, J. Duncan, P. Graham,A. Bexon,J. Spicer

European Journal of Cancer (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn